Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
If you're new to this newsletter, $4 Comments, tips? Email me at lramsey@insider.com or tweet $4. Let's get to it...
- It's been a quiet year for drug-industry mergers and acquisitions.
- Biotechs that used to be active acquirers have been bought by larger pharma players.
- $4
$4
Gigantic leaps, bad ideas, and bold bets: Venture legend Noubar Afeyan lays out the process he uses to create superstar biotechs like Moderna>$4
- Noubar Afeyan, a cofounder of the coronavirus-vaccine maker Moderna, recently sat down with Insider.
- He shared the four steps used by his venture firm Flagship Pioneering to create companies.
- $4
$4
